In neuroblastomas, abnormal receptor tyrosine kinase (RTK) activity (e.g., ALK, NTRK) occurs frequently, but the frequency of genetic aberrations of downstream effectors, such as PIK3CA is rather low [52]. This evidence concerns the gene ALK and neuroblastoma.